Filter
7664
Filtered Results: 7664
Text search:
regional
report
Featured
Recommendations
569
New Publications
2076
Language
Document type
No document type
4289
Studies & Reports
1562
Guidelines
779
Manuals
348
Strategic & Response Plan
334
Fact sheets
124
Training Material
92
Situation Updates
87
Resource Platforms
22
Brochures
11
Infographics
11
Online Courses
4
App
1
Countries / Regions
Global
337
India
230
Kenya
207
Ethiopia
204
Western and Central Europe
178
Latin America and the Carribbean
177
Nepal
156
Uganda
149
Sierra Leone
147
Liberia
137
Myanmar / Burma
131
Africa
127
Ukraine
118
South Africa
118
Ghana
112
Tanzania
112
Nigeria
107
Syria
104
Zambia
94
Malawi
88
Rwanda
87
Eastern Europe
84
Bangladesh
79
Congo, Democratic Republic of
69
Namibia
69
Senegal
64
Venezuela
63
South–East Asia Region
61
Indonesia
60
Philippines
59
Asia
59
Guinea
58
Mozambique
56
Burkina Faso
52
South Sudan
51
West and Central Africa
50
Colombia
45
East and Southern Africa
45
Brazil
45
Lesotho
43
Russia
43
Zimbabwe
41
Haiti
41
Cambodia
40
Middle East and North Africa
40
Yemen
40
Cameroon
39
Germany
39
Benin
32
Eastern Europe and Central Asia
32
Pakistan
31
Paraguay
30
Central African Republic
30
Botswana
25
Afghanistan
24
Madagascar
24
Mali
23
Eswatini/ Swaziland
23
Peru
22
Argentina
22
Jordan
21
Somalia
21
Sudan
20
Thailand
18
Western Pacific Region
18
Lebanon
17
Tajikistan
16
Albania
15
Moldova
14
USA
12
Angola
12
Iraq
12
Bolivia
11
North Macedonia
10
Turkey
10
China
10
Kyrgyzstan
10
Guinea-Bissau
10
Côte d’Ivoire / Ivory Coast
10
Georgia
10
Ecuador
10
Vietnam
9
Sri Lanka
9
Togo
8
Chile
8
Laos
8
Niger
8
Southern Africa
8
Mexico
7
Romania
7
Poland
7
Libya
7
El Salvador
6
Gambia
6
Iran
6
Burundi
6
Italy
6
Armenia
6
Hungary
6
North America
6
Papua New Guinea
6
Egypt
6
Palestine
6
Bhutan
6
Kazakhstan
5
Morocco
5
Spain
5
Chad
5
Timor Leste/ East Timor
4
Serbia
4
Uzbekistan
4
Turkmenistan
4
Tunisia
4
Belarus
4
Djibouti
4
Greece
4
Honduras
4
Estonia
3
Malaysia
3
Croatia
3
Saudi Arabia
3
Gabon
3
Uruguay
3
Jamaica
3
Mauritius
3
Portugal
3
Bosnia and Herzegovina
3
Guatemala
3
Canada
2
Singapore
2
Qatar
2
Bulgaria
2
Mauritania
2
Dominican Republic
2
Lithuania
2
Japan
2
United Kingdom
2
Azerbaijan
2
Israel
2
Slovakia
2
North Korea
1
Switzerland
1
Fiji
1
Congo-Brazzaville
1
Vanuatu
1
Mongolia
1
Ireland
1
Belgium
1
France
1
Maldives
1
Norway
1
Algeria
1
Latvia
1
Nicaragua
1
Authors & Publishers
Publication Years
Category
Countries
2924
Clinical Guidelines
496
Public Health
415
Women & Child Health
402
Key Resources
337
Capacity Building
109
Pharmacy & Technologies
72
Toolboxes
HIV
593
COVID-19
580
Mental Health
486
TB
431
Planetary Health
379
Disability
313
Rapid Response
258
Conflict
240
AMR
240
Ebola
196
NTDs
185
Refugee
176
Caregiver
158
Global Health Education
155
Pharmacy
137
NCDs
122
Natural Hazards
100
Health Financing Toolbox
93
Zika
51
Polio
48
Cholera
46
Specific Hazards
42
Social Ethics
15
Typhoon
8
Health Financing
2
South Sudan
1
Over the past few weeks, members of the C4PTF for the Ukraine Response have started mapping the different protection risks that refugees and IDPs are facing in Ukraine and while travelling. This work has been notably built upon efforts conducted in each country, such as the GBV Risk Analysis for CVA...
This guideline provides evidence-based recommendations on parenting interventions for parents and caregivers of children aged 0–17 years that are designed to reduce child maltreatment and harsh parenting, enhance the parent–child relationship, and prevent poor mental health among parents and emo...
PLoS Negl Trop Dis 15(8): e0009697. Chagas disease (CD), caused by the parasite Trypanosoma cruzi, affects ~6–7 million people worldwide. Significant limitations still exist in our understanding of CD. Harnessing individual participant data (IPD) from studies could support more in-depth analyses t...
Research and Reports in Tropical Medicine 2022:13 25–40.
Chagas disease (CD) is caused by the parasite Trypanosoma cruzi, and it is endemic in Central, South America, Mexico and the South of the United States. It is an important cause of early mortality and morbidity, and it is associated with po...
Background: The World Health Organization (WHO) published a clinical case definition of post COVID-19
condition, by a Delphi consensus, on 6 October 2021. That process concluded that a separate definition
may be applicable for children. It is important to understand the frequency, characteristics ...
Cutaneous leishmaniasis (CL) is a neglected infectious endemic disease that is transmitted through the bite of a vector insect (sandfly) of the Lutzomyia genus,typical of rural geographical territories, and causes disfiguring skin ulcers and disabilities. It is estimated that CL affects between 600 ...
Countries are making progress toward the global goal of 95% of people living with HIV knowing their status by 2025. However, considerable gaps remain in achieving these goals globally. Men in high HIV burden settings and men from key populations in all settings are consistently less likely to know t...
Despite a historical association with poor tolerability, a comprehensive review on safety of antileishmanial chemotherapies is lacking. We carried out an update of a previous systematic review of all published clinical trials in visceral leishmaniasis (VL) from 1980 to 2019 to document any reported ...
Recommandations formalisées d'experts
Sexual exploitation, sexual abuse and sexual harassment (SEAH) violate the rights and wellbeing of the people we serve and the people with whom we serve. Such behaviours are directly in opposition to WHO’s values and our abiding responsibility to do no harm. WHO uses the umbrella term “sexual mi...
Scabies is a global health concern disproportionately affecting vulnerable populations such as refugees and asylum seekers. Greece is a main point of entry in Europe for refugees, but epidemiological data on scabies in this population are scarce. We aimed to describe the epidemiology of scabies, inc...
Wiping out Trachoma from Nepal – How Nepal eliminated trachoma as a public health problem
WHO - 2018
As of 12 December 2022, over 645 million people worldwide have been diagnosed with COVID-19, with over 6.6 million deaths (4).
The Omicron variant, which emerged in late November 2021, and its subvariants, are now the dominant circulating viruses, contributing to the ongoing surge in several countr...
The WHO continuously reviews available data on SARS-CoV-2 variants of concern. For this version, the global epidemiological
situation of the COVID-19 pandemic as of 21 January 2022 – at a time when the Omicron VOC had been identified in 171
countries across all six WHO Regions and was rapidly re...
Le Nigéria a signalé son premier cas de COVID-19 vers fin février 2020. Le pays a ensuite connu quatre vagues de
contaminations avec des pics en juin 2020, janvier 2021, août 2021 et décembre 2021. La pandémie de COVID-19
a eu de graves conséquences sur l’économie du Nigéria et a entra...
Human rabies remains a significant public health problem in Africa with outbreaks reported in most countries. In Nigeria–the most populous country in Africa–rabies causes a significant public health burden partly due to perennial obstacles to implementing a national prevention and control progra...
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world.
In addition, this edition includes summary and recommendations from the virtual meeting of the members of the WHO Programme f...
Medical care for people caught up in armed conflict and other insecure environments saves lives and alleviates suffering. It is one of the most immediate and high priority needs of an affected population and is often the first type of response activated and/or requested by authorities and affected c...
Rabies is a fatal viral zoonosis and serious public health problem.1 All mammals are believed to be susceptible to the disease, and for the purposes of this document, use of the term animal refers to mammals. The disease is an acute, progressive encephalitis caused by viruses in the genus Lyssavirus...
The conditionality of this recommendation is largely driven by the current higher unit cost of pyrethroid-PBO ITNs compared
to pyrethroid-only LLINs and therefore the uncertainty of their cost-effectiveness. Furthermore, as PBO is less wash-resistant
than pyrethroids, its bioavailability declines ...
